Research at the Swedish Heart & Vascular Institute
Every Research Project at the Institute Contributes to Ongoing Evidence-Based Medical Standards
This overview of Swedish Heart & Vascular Institute Research features several physicians discussing cardiovascular research, nationally recognized staff, state-of-the-art technology, and the very best patient care.
Peripheral Vascular Disease
This video focuses on peripheral vascular disease research at Swedish Heart & Vascular Institute. Medical director of endovascular services, Dr. Robert M. Bersin, is an interventional cardiologist whose research improves patient outcomes and provides breakthrough medical care technologies. Dr. Bersin also discusses gradual improvements of existing technologies, including miniaturization and minimally invasive techniques.
Pharmaceutical drug research at Swedish Heart & Vascular Institute focuses on new blood thinning medicines used in cardiovascular medicine and also heart failure medicines. Medical director of cardiovascular research and interventional cardiologist, Dr. John L. Petersen II, is the principal investigator of numerous cardiovascular pharmaceutical trials. He discusses the importance of these trials to reducing heart failure and improving cardiovascular surgical success.
Cell-based therapy research at Swedish Heart & Vascular Institute is quintessential to medical advancement. Medical director Dr. Paul P. Huang researches stem cell therapy pertaining to cardiovascular disease. He provides an historical perspective of stem cell research and explains how stem cells can help cardiovascular patients avoid surgery and improve their quality of life. Dr. Huang believes that regenerative medicine is medicine's next frontier.
Cardiac electrophysiology research at Swedish Heart & Vascular Institute forwards the ability to manipulate catheters in the heart in three dimensions without using x-rays. Cardiac electrophysiologist Dr. Darryl S Wells describes how catheters and systems being developed today will revolutionize future patient treatment. He also cites Swedish's excellence in clinical care combined with excellence in ongoing active research.
Atrial fibrillation research at Swedish Heart & Vascular Institute focuses on eliminating or minimizing post-operative atrial fibrillation in patients. Dr. Glenn R. Barnhart, chief of cardiac surgical services, discusses Swedish's collaboration in multi-center atrial fibrillation research in order to gather the necessary statistical information to forward this evidence-based medicine.
Coronary Artery Disease
Coronary artery disease research at Swedish Heart & Vascular Institute evaluates technologies that forward angioplasty and stent procedures. Interventional cardiologist Dr. Amish J. Desai cites Swedish as a leader in cardiovascular research for over fifteen years, describing how angioplasty and stent procedures treat blockages in the blood vessels that supply the heart. Swedish joined several institutions in evaluating medication-coated stints that revolutionized cardiovascular medicine.